Salarius Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLRX and other ETFs, options, and stocks.

About SLRX

Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. 

CEO
David J. Arthur
CEODavid J. Arthur
Employees
2
Employees2
Headquarters
Houston, Texas
HeadquartersHouston, Texas
Founded
2014
Founded2014
Employees
2
Employees2

SLRX Key Statistics

Market cap
1.91M
Market cap1.91M
Price-Earnings ratio
-0.17
Price-Earnings ratio-0.17
Dividend yield
Dividend yield
Average volume
5.94M
Average volume5.94M
High today
$0.93
High today$0.93
Low today
$0.8528
Low today$0.8528
Open price
$0.869
Open price$0.869
Volume
61.59K
Volume61.59K
52 Week high
$7.20
52 Week high$7.20
52 Week low
$0.4519
52 Week low$0.4519

People also own

Based on the portfolios of people who own SLRX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.